Female customers of a health insurance plan are buying yeast infection pills for $5,800 each, according to the Healthcare Information and Analysis Council (HIAAC).
The data shows that about 40% of the women surveyed bought the yeast infection drug.
That’s a substantial increase over the previous month when the survey found only about 12% of women bought yeast medication.
“I think it’s important for the industry to know that it’s not that women are using these products out of necessity, but they are choosing to buy them because they’re concerned about the virus,” said Heather Stokke, a health policy expert at the nonprofit Center for Responsible Technology.
“It’s not about a woman’s ability to use it.
It’s about a person’s ability, their ability to take care of themselves.”
HIAAC surveyed 3,500 women and found that 40% bought the pill for a sexual enhancement benefit.
Women who took the yeast pill for yeast infections were significantly more likely to have a sex life than women who took other types of contraceptives, according a news release from the group.
Women also were more likely than women with vaginal infections to say that they planned to get married, have children, and be financially independent in the future.
In the past month, the price of yeast infection drugs has doubled, HIAac said.
The drug is prescribed by women who are using the pill to prevent yeast infections.
For women who have been sexually active, the pill is usually cheaper than vaginal contraceptives, but for women who don’t have sex but still want the contraceptive, it’s cheaper than using condoms, according the release.
“The fact that they’re charging more than vaginal contraception does seem to indicate that they are aware of that and want to make sure that they can have the best possible outcome,” said Stokka.
Stokkke has also worked on a study on how yeast infection affects women’s sex lives.
In it, she and her team found that women who take the yeast pills were more than twice as likely as those who didn’t to use condoms.
“We really don’t know what that’s doing to women’s sexual lives,” said HIAAAC’s Stokky.
“But there is some evidence that suggests that these drugs can lead to more infections in women who use them.”
In the meantime, some companies are making their own yeast pill.
A few weeks ago, an online health insurance provider, HealthLine, announced it was making an emergency contraceptive pill.
HealthLine’s chief medical officer, Dr. James Stokes, told the Washington Post that he was excited to announce the new drug and wanted to share the product with patients.
Stokes said that he expected the company would have a variety of options to choose from.
“As a company, we want to be prepared,” he said.
“So we’ve partnered with a number of companies to develop a new product that will work in different circumstances.”
He added that he wanted to make it available for everyone, even if that meant they would have to take the pill on the side.
Stoker said that the company is confident that its product will work better for women than vaginal contraceptive pills.
“One of the main concerns that we had is that women would not be able to use the pill because they would be pregnant,” he told the Post.
“That is one of the major concerns that people have when they are trying to make a decision about this.”